These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 20099776)

  • 41. Doping control in sports--a perspective from the 1996 Olympic Games.
    Ambrose PJ
    Am J Health Syst Pharm; 1997 May; 54(9):1053-7. PubMed ID: 9143653
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Why Did the Sports Pharmacists Create the Card Game?].
    Shimizu M
    Yakugaku Zasshi; 2022; 142(2):115-121. PubMed ID: 35110446
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Asthma medication in athletes: a qualitative investigation of adherence, avoidance and misuse in competitive sport.
    Allen H; Price OJ; Hull JH; Backhouse SH
    J Asthma; 2022 Apr; 59(4):811-822. PubMed ID: 33504234
    [No Abstract]   [Full Text] [Related]  

  • 44. Doping control, providing whereabouts and the importance of privacy for elite athletes.
    Valkenburg D; de Hon O; van Hilvoorde I
    Int J Drug Policy; 2014 Mar; 25(2):212-8. PubMed ID: 24462318
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Doping in athletes--an update.
    De Rose EH
    Clin Sports Med; 2008 Jan; 27(1):107-30, viii-ix. PubMed ID: 18206571
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nutritional supplements and doping.
    Pipe A; Ayotte C
    Clin J Sport Med; 2002 Jul; 12(4):245-9. PubMed ID: 12131059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Essential Features of Third-Party Certification Programs for Dietary Supplements: A Consensus Statement.
    Eichner AK; Coyles J; Fedoruk M; Maxey TD; Lenaghan RA; Novitzky J; Lindsey AT; Deuster PA
    Curr Sports Med Rep; 2019 May; 18(5):178-182. PubMed ID: 31082891
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Banned performance enhancing ergogenic aids in children and adolescent athletes].
    Nemet D; Eliakim A
    Harefuah; 2007 Oct; 146(10):794-9, 812. PubMed ID: 17990397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Consult Your Physician or Health Care Provider? Health and Legal Aspects Regarding the Use of Dietary Supplements Offered in the World Wide Web].
    Carlsohn A; Steinhorst L
    Sportverletz Sportschaden; 2018 Dec; 32(4):264-271. PubMed ID: 30537792
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmaceutical treatment of asthma symptoms in elite athletes - doping or therapy?
    Backer V; Lund T; Pedersen L
    Scand J Med Sci Sports; 2007 Dec; 17(6):615-22. PubMed ID: 18093034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of nutritional supplements among master athletes.
    Striegel H; Simon P; Wurster C; Niess AM; Ulrich R
    Int J Sports Med; 2006 Mar; 27(3):236-41. PubMed ID: 16541381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Asthma drugs and doping].
    Pillard F; Rolland Y; Rivière D
    Allerg Immunol (Paris); 1999 Nov; 31(9):317-9. PubMed ID: 10615514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Medication and supplement use by athletes.
    Ciocca M
    Clin Sports Med; 2005 Jul; 24(3):719-38, x-xi. PubMed ID: 16004927
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Specialist pharmacist training from the viewpoint of sports pharmacology].
    Kasashi K
    Yakugaku Zasshi; 2012; 132(12):1325-8. PubMed ID: 23208035
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Current Status of Doping in Japan Based on Japan Anti-Doping Disciplinary Panels of the Japan Anti-Doping Agency (JADA): A Suggestion on Anti-Doping Activities by Pharmacists in Japan].
    Imanishi T; Kawabata T; Takayama A
    Yakugaku Zasshi; 2017; 137(7):883-891. PubMed ID: 28674304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Update on banned substances 2013.
    Barnes KP; Rainbow CR
    Sports Health; 2013 Sep; 5(5):442-7. PubMed ID: 24427415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dietary supplementation patterns of Korean olympic athletes participating in the Beijing 2008 Summer Olympic Games.
    Kim J; Kang SK; Jung HS; Chun YS; Trilk J; Jung SH
    Int J Sport Nutr Exerc Metab; 2011 Apr; 21(2):166-74. PubMed ID: 21558578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Are the prevalence and treatment of asthma similar in elite athletes and the aged-matched non-athlete population?
    Locke S; Marks G
    Scand J Med Sci Sports; 2007 Dec; 17(6):623-7. PubMed ID: 17316378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Anti-doping policy development process in the sports world (1968~1999): focusing on IOC activities and passive response from Korea].
    Hwang ER; Kim TY
    Uisahak; 2014 Aug; 23(2):269-318. PubMed ID: 25223222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of therapeutic use exemptions at the Olympic Games and association with medals: an analysis of data from 2010 to 2018.
    Vernec A; Healy D
    Br J Sports Med; 2020 Aug; 54(15):920-924. PubMed ID: 32376674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.